Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
Dahhan
Talal
T
Department of Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Al Kahtani
Khalid
K
Bakshi
Nasir
N
Abouzied
Mohei Eldin Moustafa
ME
Helmy
Ahmed
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D017809:Fatal Outcome; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000139:chemically induced*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine